Mountain Hill Investment Partners’s Pfizer PFE Stock Holding History

Mountain Hill Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.53K	Buy	147 +3	+2%	+$78	﹤0.01%	123
2026 Q1	$4.05K	Sell	144 -623	-81%	-$16.6K	﹤0.01%	117
2025 Q4	$19.1K	Sell	767 -1,998	-72%	-$50.4K	0.01%	99
2025 Q3	$70.4K	Buy	2,765 +628	+29%	+$15.5K	0.06%	52
2025 Q2	$51.8K	Buy	2,137 +2	+0.1%	+$47	0.04%	63
2025 Q1	$54.1K	Buy	2,135 +2	+0.1%	+$52	0.05%	60
2024 Q4	$56.6K	Buy	+2,133	New	+$57.9K	0.06%	60

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Mountain Hill Investment Partners's PFE Position: Q2 2026 in Review

Mountain Hill Investment Partners increased its Pfizer (PFE) stake by 2.1% in Q2 2026, buying an estimated $78 and bringing the position to 147 shares worth $3.53K. The position accounts for ﹤0.01% of the portfolio, ranked #123.

Mountain Hill Investment Partners first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $70.4K in Q3 2025. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Mountain Hill Investment Partners held 147 shares of Pfizer worth $3.53K as of Q2 2026.
Mountain Hill Investment Partners bought 3 Pfizer shares in Q2 2026, an estimated $78.
Pfizer made up ﹤0.01% of Mountain Hill Investment Partners's portfolio in Q2 2026, its #123 holding.
Mountain Hill Investment Partners first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Mountain Hill Investment Partners's Pfizer position peaked at $70.4K in Q3 2025.
900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Mountain Hill Investment Partners's 13F filing for Q2 2026, filed 16 Jul 2026.